Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Sequencing of patient-derived xenografts in NSG mice

ABSTRACT: Variant analysis of patient-derived xenografts in NSG mice

PROVIDER: PRJEB52345 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	ERR9615990_1.fastq.gz	Fastqsanger.gz
	ERR9615990_2.fastq.gz	Fastqsanger.gz
	ERR9616000_1.fastq.gz	Fastqsanger.gz
	ERR9616000_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 1155

Similar Datasets

RNA-seq expression analysis of patient-derived xenografts in NSG mice

Project description:RNA-seq expression analysis of patient-derived xenografts in NSG mice

| PRJEB38645 | ENA

Stranded RNA-seq expression analysis of patient-derived xenografts in NSG mice

Project description:Stranded RNA-seq expression analysis of patient-derived xenografts in NSG mice

| PRJEB38807 | ENA

Thoracic patient-derived xenografts

Project description:Thoracic patient-derived xenografts

| PRJNA339191 | ENA

RNA-seq expression analysis of patient-derived xenografts in NSG mice--Baylor breast cancer models

Project description:RNA-seq expression analysis of patient-derived xenografts in NSG mice--Baylor breast cancer models

| PRJEB38655 | ENA

Patient-derived Human Breast Cancer Xenografts

Project description:Breast cancer research is hampered by difficulties in obtaining and studying primary human breast tissue, and by the lack of in vivo preclinical models that reflect patient tumor biology accurately. To overcome these limitations, we propagated a cohort of human breast tumors grown in the epithelium-free mammary fat pad of SCID/Beige and NOD/SCID/IL2γ-receptor null (NSG) mice, under a series of transplant conditions. Both models yielded stably transplantable xenografts at comparably high rates (~23% and ~19%, respectively). Of the conditions tested, xenograft take rate was highest in the presence of a low-dose estradiol pellet. Overall, 32 stably transplantable xenograft lines were established, representing unique 25 patients. Most tumors yielding xenografts were “triple-negative” (ER-PR-HER2+) (n=19). However, we established lines from three ER-PR-HER2+ tumors, one ER+PR-HER2-, one ER+PR+HER2- and one “triple-positive” (ER+PR+HER2+) tumor. Serially passaged xenografts show biological consistency with the tumor of origin, are phenotypic stability across multiple transplant generations at the histological, transcriptomic, proteomic, and genomic levels, and show comparable treatment responses. Xenografts representing 12 patients, including two ER+ lines, showed metastasis to the mouse lung. These models thus serve as a renewable, quality-controlled tissue resource for preclinical studies investigating treatment response and metastasis. The study was designed to determine how stable patient-derived xenografts are across multiple transplant generations in mice, and to determine how closely xenografts established with pre-treatment samples cluster with xenografts established with post-treatment samples. Overall, pre-treatment and post-treatment samples derived from the same patient cluster together, and multiple transplant generations of xenografts derived from an individual patient cluster together.

2013-05-30 | E-GEOD-46106 | biostudies-arrayexpress

RNA sequencing of Patient-Derived Xenografts

Project description:RNA sequencing of Patient-Derived Xenografts

| PRJNA1026533 | ENA

RNA-seq expression analysis of patient-derived xenografts in NSG mice--Dana-Farber Cancer Institute blood cancers

Project description:RNA-seq expression analysis of patient-derived xenografts in NSG mice--Dana-Farber Cancer Institute blood cancers

| PRJEB38661 | ENA

scRNA-seq of pediatric glioblastoma patient-derived xenografts

Project description:scRNA-seq of patient-derived xenografts.

2019-03-15 | GSE117599 | GEO

Proteomics of prostate cancer patient derived xenografts

Project description:A set of 17 prostate cancer patient-derived xenografts (PDX, Lin et al 2014, Cancer research) was analyzed by mass spectrometry-based proteomics to characterize the effects of castration in vivo, and the proteome differences between NEPC and prostate adenocarcinomas.

2019-09-11 | PXD009636 | Pride

scRNA-seq of pediatric glioblastoma patient-derived xenografts

Project description:scRNA-seq of pediatric glioblastoma patient-derived xenografts

| PRJNA482625 | ENA